期刊文献+

O/W型药用微乳的制备及评价 被引量:13

Preparation and Evaluation of O/W Pharmaceutical Microemulsions
下载PDF
导出
摘要 【目的】研究O/W型药用微乳形成的基本规律及评价方法,为药用微乳的研究和应用提供一定的实验依据。【方法】通过滴定法绘制拟三元相图,考察不同表面活性剂和助表面活性剂对O/W型微乳形成的影响。【结果】在相同油相的情况下,不同表面活性剂和助表面活性剂的不同结构和性质、表面活性剂和助表面活性剂的质量比(Km)、温度的变化对微乳的形成均有影响。【结论】恰当的油相和适配的表面活性剂和助表面活性剂的合理搭配,可以使微乳体系中表面活性剂的用量降低至7.5%,而且一般微乳形成的区域大小与表面活性剂和助表面活性剂的总量成正比,与油的用量成反比。用三元相图作为选择最佳微乳组方需要结合微乳的稳定性考察来确定微乳的最佳形成条件。 Objective The basic formation rules and evaluation of the pharmaceutical microemulsions were studied in order to provide some experimental information to studying and application of pharmaceutical microemulsions.Method The titrimetric method for drawing pseudo-ternary phase diagrams was used to inspect the formation influence caused by different surfactants and CO-surfactant on the O/W microemulsions.Result In the same oil phase situation,the formation of microemulsions would be influenced by the structure and nature of surfactant and CO-surfactant, the quality ratio (Km) of surfactant and CO-surfactan as well as the temperature. [Conclusion] Appropriate oil phase and suitable matches of the surfactant and CO-surfactant can reduce the drawing pseudo-temary phase diagrams to determine the most excellent formation condition of pharmaceutical microemulsions, the stability of microemulsions needs to be unified.
出处 《中国农业科学》 CAS CSCD 北大核心 2009年第9期3328-3333,共6页 Scientia Agricultura Sinica
基金 国家高技术研究发展计划(“863”计划)重大课题(2006AA10A203) 中央级公益性科研院所基本科研业务费专项资金项目(BRF070405)
关键词 微乳 助表面活性剂 非离子型表面活性剂 拟三元相图 pharmaceutical microemulsions CO-surfactant non-ionic surfactant pseudo-ternary phase diagram
  • 相关文献

参考文献24

  • 1Pouton C W. Formulation of self-emulsifying drug deliverysystems. Advanced Drug Delivery Reviews, 1997, 25(1): 47-58.
  • 2Uchegbu I F. Non-ionic surfaetant based vesicles (niosomes)in drug delivrery. International Journal of Pharmaeeutics, 1998, 172(1): 33.
  • 3王晓黎,蒋雪涛,刘皋林,钱方,郭守成.O/W型微乳对水难溶性药物增溶作用的研究[J].第二军医大学学报,2002,23(1):84-86. 被引量:23
  • 4Erol Yilmaz, Hans-Hubert Borchert. Design of a phytosphingosine- containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. European Journal of Pharmaceutics and Biopharmaceutics, 2005, 60:91-98.
  • 5Nomoo A O, Diana S L. Chow. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics. International Journal of Pharmaceutics, 2008, 349: 117-123.
  • 6Jayne L M, Gareth D R. Microemulsion-based media as noveldrug delivery systems. Advanced Drug Delivery Reviews, 2005, 45: 89-121.
  • 7Shafiq S, Shakeet F, Talegaonkar S. Development and bioavailability assessment of ramipra nanoemulsion formulation. European Journal of Pharmaceutics and Biopharmaeeutie, 2007, 66(2): 227-243.
  • 8Trimaille T, Chaix C, Delair T. Interfacial depositon offunctionalized copolymers onto nanoemulsions produced by the solvent displacement method. Colloid and Polymer Science, 2001, (279): 784-792.
  • 9吴旭锦,欧阳五庆,朱小甫,杨宝平.黄芩甙纳米乳的制备[J].精细化工,2007,24(5):470-472. 被引量:14
  • 10何蕾,王桂玲,张强.紫杉醇纳米乳剂的体内外考察[J].药学学报,2003,38(3):227-230. 被引量:41

二级参考文献77

共引文献257

同被引文献142

引证文献13

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部